Player FM ऐप के साथ ऑफ़लाइन जाएं!
68. CRISPR and molecular aging
Manage episode 356157183 series 2508237
What do CRISPR and longevity have in common? Not much, except it's all molecular.
We spoke to two different CEOs focused on improving human health. We begin with Dr Benjamin Oakes, Co-Founder, President, and CEO of Scribe Therapeutics, who takes us through the discovery, potential, and possible limitations of CRISPR.
Then we are joined by fellow visionary Kristen Fortney, the CEO and co-founder of BioAge, a clinical-stage biotechnology company developing therapies that treat disease by targeting the biology of ageing.
You cannot miss these fascinating conversations.
Keywords: ageing, CRISPR, molecules, age, technology, disease, muscle, engineering, treat, understand, genome editing, human, Jennifer Doudna.
89 एपिसोडस
Manage episode 356157183 series 2508237
What do CRISPR and longevity have in common? Not much, except it's all molecular.
We spoke to two different CEOs focused on improving human health. We begin with Dr Benjamin Oakes, Co-Founder, President, and CEO of Scribe Therapeutics, who takes us through the discovery, potential, and possible limitations of CRISPR.
Then we are joined by fellow visionary Kristen Fortney, the CEO and co-founder of BioAge, a clinical-stage biotechnology company developing therapies that treat disease by targeting the biology of ageing.
You cannot miss these fascinating conversations.
Keywords: ageing, CRISPR, molecules, age, technology, disease, muscle, engineering, treat, understand, genome editing, human, Jennifer Doudna.
89 एपिसोडस
सभी एपिसोड
×प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।